Terms: = Brain cancer AND ROS1, ROS, 6098, ENSG00000047936, P08922, MCF3, RP1-179P9_1 AND Clinical Outcome
664 results:
1. Narrow interval dual phase 18F-FDG PET/CT: A practical approach for distinguishing tumor recurrence from radiation necrosis in brain metastasis.
Aggarwal A; Aggarwal AK; Prakash S; Vile DJ; Aggarwal A
Medicine (Baltimore); 2024 May; 103(18):e37789. PubMed ID: 38701250
[TBL] [Abstract] [Full Text] [Related]
2. Prognosis versus Actual outcomes in Stereotactic Radiosurgery of brain Metastases: Reliability of Common Prognostic Parameters and Indices.
Mangesius J; Seppi T; Arnold CR; Mangesius S; Kerschbaumer J; Demetz M; Minasch D; Vorbach SM; Sarcletti M; Lukas P; Nevinny-Stickel M; Ganswindt U
Curr Oncol; 2024 Mar; 31(4):1739-1751. PubMed ID: 38668035
[TBL] [Abstract] [Full Text] [Related]
3. Microsurgical removal of supratentorial and cerebellar cavernous malformations: what has changed? A single institution experience.
Meneghelli P; Pasqualin A; Musumeci A; Pinna G; Berti PP; Polizzi GMV; Sinosi FA; Nicolato A; Sala F
J Clin Neurosci; 2024 May; 123():162-170. PubMed ID: 38581776
[TBL] [Abstract] [Full Text] [Related]
4. [
Pruis IJ; Verburg FA; Balvers RK; Harteveld AA; Feelders RA; Vernooij MW; Smits M; Neggers SJCMM; Veldhuijzen van Zanten SEM
J Nucl Med; 2024 May; 65(5):688-692. PubMed ID: 38514085
[TBL] [Abstract] [Full Text] [Related]
5. [Neurosurgical treatment of tumors of the pineal region - literature review and overview of cases at OMIII].
Mezei T; Báskay J; Pollner P; Kovács V; Markia B; Nagy G; Bajcsay A; Sipos L
Magy Onkol; 2024 Mar; 68(1):27-35. PubMed ID: 38484373
[TBL] [Abstract] [Full Text] [Related]
6. Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma.
Vella V; Ditsiou A; Chalari A; Eravci M; Wooller SK; Gagliano T; Bani C; Kerschbamer E; Karakostas C; Xu B; Zhang Y; Pearl FMG; Lopez G; Peng L; Stebbing J; Klinakis A; Giamas G
Adv Sci (Weinh); 2024 Apr; 11(15):e2306027. PubMed ID: 38353396
[TBL] [Abstract] [Full Text] [Related]
7. Effect of continuous hypertonic saline infusion on clinical outcomes in patients with traumatic brain injury.
Peng C; Chi L; Chen M; Peng L; Yang F; Shao L; Bo L; Jin Z
Neurosurg Rev; 2024 Feb; 47(1):78. PubMed ID: 38340147
[TBL] [Abstract] [Full Text] [Related]
8. Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature.
Kritikos M; Vivanco-Suarez J; Teferi N; Lee S; Kato K; Eschbacher KL; Bathla G; Buatti JM; Hitchon PW
Neurosurg Rev; 2024 Feb; 47(1):75. PubMed ID: 38319484
[TBL] [Abstract] [Full Text] [Related]
9. GammaTile
Yekula A; Gessler DJ; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
J Neurooncol; 2024 Feb; 166(3):441-450. PubMed ID: 38281303
[TBL] [Abstract] [Full Text] [Related]
10. National multicentered retrospective review of clinical and intraoperative factors associated with the development of cerebellar mutism after pediatric posterior fossa tumor resection.
Kameda-Smith MM; Ragulojan M; Elliott C; Bliss L; Moore H; Sader N; Alsuwaihel M; Tso MK; Dakson A; Ajani O; Yarascavitch B; Fleming A; Mehta V; Aminnejad M; Farrokhyar F; Singh SK;
Childs Nerv Syst; 2024 May; 40(5):1339-1347. PubMed ID: 38279985
[TBL] [Abstract] [Full Text] [Related]
11. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
12. The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.
Garcia MA; Turner A; Brachman DG
J Neurooncol; 2024 Jan; 166(2):203-212. PubMed ID: 38261141
[TBL] [Abstract] [Full Text] [Related]
13. The Application of Sodium Fluorescein in Resection of Medulloblastoma Under YELLOW 560 Filter: Feasibility and Preliminary Results of a Monocentric Cohort and Systematic Review.
Falco J; Broggi M; Rubiu E; Schiariti M; Restelli F; Mazzapicchi E; La Corte E; Ferroli P; Acerbi F
World Neurosurg; 2024 Mar; 183():e386-e394. PubMed ID: 38154682
[TBL] [Abstract] [Full Text] [Related]
14. clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
[TBL] [Abstract] [Full Text] [Related]
15. PATIENT-RELATED FACTORS AND clinical MANAGEMENT outcomeS OF RETINOBLASTOMA IN CALABAR, NIGERIA.
Nkanga ED; Nlemadim AC; Arazi M; Nkanga DG; Duke RE; Fabian ID; Nkanga ED; Odey FA; Meremikwu MM
West Afr J Med; 2023 Dec; 40(12 Suppl 1):S36-S37. PubMed ID: 38070170
[TBL] [Abstract] [Full Text] [Related]
16. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
17. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS; Aherrahrou Z; Grasshoff H; Heidorn MW; Humrich JY; Johanson L; Aherrahrou R; Reinberger T; Schulz A; Ten Cate V; Robles AP; Koeck T; Rapp S; Lange T; Brachaczek L; Luebber F; Erdmann J; Heidecke H; Schulze-Forster K; Dechend R; Lackner KJ; Pfeiffer N; Ghaemi Kerahrodi J; Tüscher O; Schwarting A; Strauch K; Münzel T; Prochaska JH; Riemekasten G; Wild PS
Eur Heart J; 2023 Dec; 44(47):4935-4949. PubMed ID: 37941454
[TBL] [Abstract] [Full Text] [Related]
18. Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer.
Hwang N; Yoon BK; Chun KH; Kim H; Lee Y; Kim JW; Jeon H; Kim TH; Kim MY; Fang S; Cheong JH; Kim JW
Exp Mol Med; 2023 Nov; 55(11):2461-2472. PubMed ID: 37919422
[TBL] [Abstract] [Full Text] [Related]
19. Subarachnoid hemorrhage due to pituitary adenoma apoplexy-case report and review of the literature.
Yildiz Y; Lauber A; Char NV; Bozinov O; Neidert MC; Hostettler IC
Neurol Sci; 2024 Mar; 45(3):997-1005. PubMed ID: 37872321
[TBL] [Abstract] [Full Text] [Related]
20. clinical outcomes of
Hansen KH; Johansen JS; Urbanska EM; Meldgaard P; Hjorth-Hansen P; Kristiansen C; Stelmach M; Santoni-Rugiu E; Ulhøi MP; Dydensborg AB; Dünweber C; Andersen JL
Acta Oncol; 2023 Dec; 62(12):1775-1783. PubMed ID: 37815923
[TBL] [Abstract] [Full Text] [Related]
[Next]